Drug Side Effects
Search
LEUKAEMIC LYMPHOMA
LEUKAEMIC LYMPHOMA
was reported 38 times
LEUKAEMIC LYMPHOMA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Carboxypeptidase [EPC]
1
0.0028
1
Bispecific CD20-directed CD3 T Cell Engager [EPC]
3
0.0007
2
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]
1
0.0001
3
Alkylating Drug [EPC]
12
0.0000
4
Iron Chelator [EPC]
1
0.0000
5
BCL-2 Inhibitor [EPC]
2
0.0000
6
Janus Kinase Inhibitor [EPC]
5
0.0000
7
Dipeptidyl Peptidase 4 Inhibitor [EPC]
1
0.0000
8
Platinum-based Drug [EPC]
8
0.0000
9
Nucleoside Metabolic Inhibitor [EPC]
8
0.0000
10
Folate Analog Metabolic Inhibitor [EPC]
10
0.0000
11
Hepatitis C Virus NS5A Inhibitor [EPC]
1
0.0000
12
Aromatase Inhibitor [EPC]
2
0.0000
13
CD20-directed Cytolytic Antibody [EPC]
5
0.0000
14
Corticosteroid [EPC]
16
0.0000
15
Nucleoside Analog Antiviral [EPC]
1
0.0000
16
gamma-Aminobutyric Acid-ergic Agonist [EPC]
1
0.0000
17
Kinase Inhibitor [EPC]
5
0.0000
18
Calcineurin Inhibitor Immunosuppressant [EPC]
1
0.0000
19
Microtubule Inhibitor [EPC]
1
0.0000
20
Xanthine Oxidase Inhibitor [EPC]
1
0.0000
21
Interferon beta [EPC]
1
0.0000
22
beta-Adrenergic Blocker [EPC]
1
0.0000
23
Thalidomide Analog [EPC]
1
0.0000
24
Tumor Necrosis Factor Blocker [EPC]
1
0.0000